FMO5 and brain disorder: In several in vitro studies, the activation of HO-1 has confirmed neuroprotective effects against brain diseases by relieving neuroinflammation by inhibiting the production of NADPH oxidase and reactive quinones, which are key enzymes responsible for the release of reactive oxygen in microglia [61,62,63,64].